Osteopontin Stimulates Cell Motility and Nuclear Factor κB-mediated Secretion of Urokinase Type Plasminogen Activator through Phosphatidylinositol 3-Kinase/Akt Signaling Pathways in Breast Cancer Cells

This publication has 49 references indexed in Scilit:

• Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways
  Oncogene, 2003
• Syk, a Protein-tyrosine Kinase, Suppresses the Cell Motility and Nuclear Factor κB-mediated Secretion of Urokinase Type Plasminogen Activator by Inhibiting the Phosphatidylinositol 3′-Kinase Activity in Breast Cancer Cells
  Published by Elsevier ,2003
• Phosphatidylinositol 3-Kinase and NF-κB Regulate Motility of Invasive MDA-MB-231 Human Breast Cancer Cells by the Secretion of Urokinase-type Plasminogen Activator
  Journal of Biological Chemistry, 2002
• Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells
  Oncogene, 1999
• Altered wound healing in mice lacking a functional osteopontin gene (spp1).
  Journal of Clinical Investigation, 1998
• Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.
  Journal of Clinical Investigation, 1997
• uPA, uPAR, PAI-I: Key intersection of proteolytic, adhesive and chemotacfic highways?
  Immunology Today, 1997
• THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
  Annual Review of Immunology, 1996
• Secreted phosphoprotein mrna is induced during multi‐stage carcinogenesis in mouse skin and correlates with the metastatic potential of murine fibroblasts
  International Journal of Cancer, 1990
• A secreted phosphoprotein marker for neoplastic transformation of both epithelial and fibroblastic cells
  Nature, 1983